Yoshio Tomizawa
Shibukawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: Chemotherapy
Published: January 21, 2020
Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression.
Journal: Expert opinion on pharmacotherapy
Published: June 07, 2018
A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: August 23, 2017
High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.
Journal: International journal of clinical oncology
Published: February 24, 2017
Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting.
Journal: Anticancer research
Published: January 22, 2017
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: November 12, 2016
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy.
Journal: Chemotherapy
Published: November 08, 2016
Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: October 25, 2016
Lung Segmentectomy Using Video-assisted Thoracic Surgery for Lung Cancer in a Patient with Situs Inversus Totalis
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: July 02, 2016
Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: June 09, 2016
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.
Journal: Oncology letters
Published: March 29, 2016
Last Updated: 09/26/2026